Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Focus on moderate activities like walking, and ensure adequate rest between exercise sessions
Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM
You are in the best position to consider stopping when: you have been at a stable goal weight for at least 36 months
Clinical trials show Wegovy leads to greater average weight loss than Saxenda, although individual results vary
A 2026 study published in Cardiovascular Diabetology found an association between GLP-1 use and lower risks of heart attack, stroke, heart failure and premature death among high-risk patients building on earlier evidence from Novo Nordisk's SELECT trial, which showed that Wegovy reduced major adverse cardiovascular events versus placebo in people with established heart disease
US$ 24.07
US$ 28.69
US$ 27.39
US$ 27.30
